| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 4-phosphatase activity | 4.31e-07 | 10 | 137 | 4 | GO:0034596 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate phosphatase activity | 1.26e-06 | 4 | 137 | 3 | GO:0043812 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 2.73e-06 | 15 | 137 | 4 | GO:0052744 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 5.06e-05 | 30 | 137 | 4 | GO:0052866 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 8.59e-05 | 13 | 137 | 3 | GO:0034595 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 1.09e-04 | 14 | 137 | 3 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 1.66e-04 | 16 | 137 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 6.88e-04 | 6 | 137 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 7.32e-04 | 26 | 137 | 3 | GO:0097602 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 8.19e-04 | 27 | 137 | 3 | GO:0034593 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | CYLD USP34 TRIML1 ABCA2 CAND1 RNF152 LRSAM1 UBR4 LRRK2 USP24 USP9Y TRIM52 CUL5 KLHL3 RNF7 RNF38 DCUN1D3 TRIM49B CRBN PINK1 | 2.53e-05 | 1074 | 136 | 20 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | CYLD USP34 TRIML1 CAND1 RNF152 LRSAM1 UBR4 LRRK2 USP24 USP9Y TRIM52 CUL5 KLHL3 RNF7 RNF38 DCUN1D3 TRIM49B CRBN PINK1 | 3.54e-05 | 1009 | 136 | 19 | GO:0070647 |
| GeneOntologyBiologicalProcess | negative regulation of vacuolar transport | 4.32e-05 | 2 | 136 | 2 | GO:1903336 | |
| GeneOntologyBiologicalProcess | negative regulation of late endosome to lysosome transport | 4.32e-05 | 2 | 136 | 2 | GO:1902823 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol dephosphorylation | 4.34e-05 | 30 | 136 | 4 | GO:0046856 | |
| Domain | ARM-type_fold | USP34 CAND1 ZBTB7C UBR4 LRRK2 INTS1 USP24 FHOD3 USP9Y ARMCX1 NCDN RYR3 FOCAD NOM1 VPS35 PPP6R2 STAG3 GPRASP2 | 5.11e-11 | 339 | 136 | 18 | IPR016024 |
| Domain | Syja_N | 1.34e-08 | 5 | 136 | 4 | PF02383 | |
| Domain | SAC | 1.34e-08 | 5 | 136 | 4 | PS50275 | |
| Domain | SAC_dom | 1.34e-08 | 5 | 136 | 4 | IPR002013 | |
| Domain | NACHT | 2.14e-05 | 23 | 136 | 4 | PS50837 | |
| Domain | NACHT_NTPase | 2.14e-05 | 23 | 136 | 4 | IPR007111 | |
| Domain | Ankyrin_rpt | RAPH1 PPP1R12B POTEG LRRK2 POTEB2 TNNI3K POTEJ POTEH POTEB PPP1R16A | 2.24e-05 | 262 | 136 | 10 | IPR002110 |
| Domain | EIF3C_N_dom | 5.26e-05 | 2 | 136 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 5.26e-05 | 2 | 136 | 2 | PF05470 | |
| Domain | EIF3C | 5.26e-05 | 2 | 136 | 2 | IPR027516 | |
| Domain | Ankyrin_rpt-contain_dom | PPP1R12B POTEG LRRK2 POTEB2 TNNI3K POTEJ POTEH POTEB PPP1R16A | 1.03e-04 | 254 | 136 | 9 | IPR020683 |
| Domain | ARM-like | 1.63e-04 | 270 | 136 | 9 | IPR011989 | |
| Domain | ANK | 5.11e-04 | 251 | 136 | 8 | SM00248 | |
| Domain | DAPIN | 5.26e-04 | 22 | 136 | 3 | PS50824 | |
| Domain | PYRIN | 5.26e-04 | 22 | 136 | 3 | SM01289 | |
| Domain | PYRIN | 5.26e-04 | 22 | 136 | 3 | PF02758 | |
| Domain | DAPIN | 5.26e-04 | 22 | 136 | 3 | IPR004020 | |
| Domain | ANK_REPEAT | 5.38e-04 | 253 | 136 | 8 | PS50088 | |
| Domain | ANK_REP_REGION | 5.52e-04 | 254 | 136 | 8 | PS50297 | |
| Domain | - | 7.75e-04 | 6 | 136 | 2 | 3.90.1290.10 | |
| Domain | Plectin | 1.08e-03 | 7 | 136 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.08e-03 | 7 | 136 | 2 | IPR001101 | |
| Domain | PLEC | 1.08e-03 | 7 | 136 | 2 | SM00250 | |
| Domain | USP_CS | 1.37e-03 | 66 | 136 | 4 | IPR018200 | |
| Domain | Ank | 1.42e-03 | 228 | 136 | 7 | PF00023 | |
| Domain | USP_1 | 1.70e-03 | 70 | 136 | 4 | PS00972 | |
| Domain | UCH | 1.79e-03 | 71 | 136 | 4 | PF00443 | |
| Domain | USP_2 | 1.79e-03 | 71 | 136 | 4 | PS00973 | |
| Domain | Copine | 1.83e-03 | 9 | 136 | 2 | PF07002 | |
| Domain | Copine | 1.83e-03 | 9 | 136 | 2 | IPR010734 | |
| Domain | USP_3 | 1.89e-03 | 72 | 136 | 4 | PS50235 | |
| Domain | USP_dom | 1.89e-03 | 72 | 136 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.89e-03 | 72 | 136 | 4 | IPR001394 | |
| Domain | - | 2.29e-03 | 248 | 136 | 7 | 1.25.40.20 | |
| Domain | ARM-rpt_dom | 2.77e-03 | 11 | 136 | 2 | IPR006911 | |
| Domain | Arm_2 | 2.77e-03 | 11 | 136 | 2 | PF04826 | |
| Domain | ABC_A | 3.31e-03 | 12 | 136 | 2 | IPR026082 | |
| Domain | SPRY | 3.75e-03 | 87 | 136 | 4 | SM00449 | |
| Domain | - | 4.76e-03 | 93 | 136 | 4 | 1.10.533.10 | |
| Domain | Ank_2 | 4.94e-03 | 215 | 136 | 6 | PF12796 | |
| Domain | SPRY | 4.95e-03 | 94 | 136 | 4 | PF00622 | |
| Domain | SPRY_dom | 4.95e-03 | 94 | 136 | 4 | IPR003877 | |
| Domain | EF-hand_1 | 5.12e-03 | 152 | 136 | 5 | PF00036 | |
| Domain | B30.2/SPRY | 5.14e-03 | 95 | 136 | 4 | IPR001870 | |
| Domain | B302_SPRY | 5.14e-03 | 95 | 136 | 4 | PS50188 | |
| Domain | ConA-like_dom | 5.40e-03 | 219 | 136 | 6 | IPR013320 | |
| Domain | PINT | 5.91e-03 | 16 | 136 | 2 | SM00088 | |
| Domain | DEATH-like_dom | 5.94e-03 | 99 | 136 | 4 | IPR011029 | |
| Domain | EFh | 6.02e-03 | 158 | 136 | 5 | SM00054 | |
| Domain | ZF_RING_2 | 6.23e-03 | 298 | 136 | 7 | PS50089 | |
| Domain | PCI_dom | 6.66e-03 | 17 | 136 | 2 | IPR000717 | |
| Domain | PCI | 6.66e-03 | 17 | 136 | 2 | PF01399 | |
| Domain | EF_HAND_2 | 6.95e-03 | 231 | 136 | 6 | PS50222 | |
| Domain | RING | 7.05e-03 | 305 | 136 | 7 | SM00184 | |
| Domain | EF_hand_dom | 7.10e-03 | 232 | 136 | 6 | IPR002048 | |
| Pubmed | PLEKHB2 CYLD USP34 PDE2A ABCA2 CAND1 DSP LRSAM1 UBR4 USP9Y AKAP8L TRIM52 RYR3 FOCAD FBN1 DST APPL2 PTPRK SACS ARHGEF10 RNF38 EXOC1 EIF3C GPRASP2 PINK1 | 4.51e-11 | 1285 | 138 | 25 | 35914814 | |
| Pubmed | 3.54e-09 | 6 | 138 | 4 | 17171436 | ||
| Pubmed | 1.64e-08 | 8 | 138 | 4 | 12475935 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 USP34 PDE3A CAND1 PSMA1 LRSAM1 CAPN1 UBR4 USP24 DDI2 VPS36 NCDN NPLOC4 DDX1 EIF3CL SPDL1 CUL5 APPL2 ARHGEF10 VPS35 EIF3C | 3.10e-07 | 1455 | 138 | 21 | 22863883 |
| Pubmed | Characterization of the mammalian family of DCN-type NEDD8 E3 ligases. | 6.95e-07 | 18 | 138 | 4 | 26906416 | |
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 15276201 | ||
| Pubmed | 4.23e-06 | 163 | 138 | 7 | 24316575 | ||
| Pubmed | KNTC1 NLRP7 RAPH1 DSP PCDHGA11 PPP1R12B UBR4 CCDC150 VPS36 LCP1 TERF2 AKAP8L DDX1 BPTF DST SACS VPS35 KRT40 POTEJ | 4.52e-06 | 1442 | 138 | 19 | 35575683 | |
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 37149635 | ||
| Pubmed | 7.12e-06 | 418 | 138 | 10 | 34709266 | ||
| Pubmed | USP34 IFT140 ABCA2 SETX CAND1 INPP5F NPLOC4 TUBGCP6 DST SYNJ2 CARNS1 | 9.20e-06 | 529 | 138 | 11 | 14621295 | |
| Pubmed | SETX AKAP8L NCDN NPLOC4 DDX1 SACM1L CUL5 DST NOM1 PRKCI PPP6R2 CMTR2 | 1.18e-05 | 650 | 138 | 12 | 38777146 | |
| Pubmed | Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. | 1.31e-05 | 12 | 138 | 3 | 35512830 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CAND1 DSP PSMA1 CAPN1 LRRK2 VPS36 LCP1 SLC44A4 VPS13D GK2 APPL2 VPS35 ATP6V0A4 GSTCD PRKCI | 1.34e-05 | 1016 | 138 | 15 | 19056867 |
| Pubmed | 1.39e-05 | 130 | 138 | 6 | 12421765 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20131966 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26095046 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16771836 | ||
| Pubmed | Kinase signaling dysfunction in Parkinson's disease: a reverse genetic approach in Drosophila. | 1.56e-05 | 2 | 138 | 2 | 22486164 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 1.56e-05 | 2 | 138 | 2 | 36157221 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21880733 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27975167 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 37865315 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 32631998 | ||
| Pubmed | Identification and characterization of a sac domain-containing phosphoinositide 5-phosphatase. | 1.56e-05 | 2 | 138 | 2 | 11274189 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30269386 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 38368930 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12038792 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22764206 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18414909 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25403012 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19940141 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26947123 | ||
| Pubmed | 2.15e-05 | 14 | 138 | 3 | 20403135 | ||
| Pubmed | 2.15e-05 | 14 | 138 | 3 | 12563287 | ||
| Pubmed | Rab40-Cullin5 complex regulates EPLIN and actin cytoskeleton dynamics during cell migration. | 3.30e-05 | 16 | 138 | 3 | 33999101 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD DOCK4 SETX RAPH1 DSP INPP5F DDX1 VPS13D DST AKAP9 ARHGEF10 SYNJ2 PRKCI | 4.12e-05 | 861 | 138 | 13 | 36931259 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 4.50e-05 | 235 | 138 | 7 | 30258100 | |
| Pubmed | 4.63e-05 | 322 | 138 | 8 | 26514267 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15590904 | ||
| Pubmed | A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease. | 4.68e-05 | 3 | 138 | 2 | 19726410 | |
| Pubmed | Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. | 4.68e-05 | 3 | 138 | 2 | 17704206 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 24327761 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19252089 | ||
| Pubmed | RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. | 4.68e-05 | 3 | 138 | 2 | 23395371 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 38862989 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 29743203 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 17028906 | ||
| Pubmed | Biochemical characterization of copine: a ubiquitous Ca2+-dependent, phospholipid-binding protein. | 4.68e-05 | 3 | 138 | 2 | 11123945 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 16361262 | ||
| Pubmed | Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity. | 4.68e-05 | 3 | 138 | 2 | 33135724 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25142583 | ||
| Pubmed | 5.34e-05 | 101 | 138 | 5 | 9872452 | ||
| Pubmed | 5.65e-05 | 19 | 138 | 3 | 22405651 | ||
| Pubmed | KNTC1 USP34 CPNE8 CAND1 PSMA1 UBR4 AKAP8L NPLOC4 DDX1 SACM1L CUL5 NBAS DST NOM1 VPS35 EXOC1 EIF3C | 5.95e-05 | 1440 | 138 | 17 | 30833792 | |
| Pubmed | 6.42e-05 | 105 | 138 | 5 | 22493164 | ||
| Pubmed | 7.72e-05 | 446 | 138 | 9 | 24255178 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 8.37e-05 | 179 | 138 | 6 | 36261009 | |
| Pubmed | 8.91e-05 | 22 | 138 | 3 | 30587576 | ||
| Pubmed | Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling. | 8.91e-05 | 22 | 138 | 3 | 26811477 | |
| Pubmed | 9.28e-05 | 457 | 138 | 9 | 22190034 | ||
| Pubmed | LRRK2 gene in Parkinson disease: mutation analysis and case control association study. | 9.33e-05 | 4 | 138 | 2 | 16157901 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 36253371 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 19692353 | ||
| Pubmed | Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. | 9.33e-05 | 4 | 138 | 2 | 18211709 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 25216516 | ||
| Pubmed | Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease. | 9.33e-05 | 4 | 138 | 2 | 22445250 | |
| Pubmed | DCUN1D3 activates SCFSKP2 ubiquitin E3 ligase activity and cell cycle progression under UV damage. | 9.33e-05 | 4 | 138 | 2 | 27542266 | |
| Pubmed | Structural imaging in the presymptomatic stage of genetically determined parkinsonism. | 9.33e-05 | 4 | 138 | 2 | 20483373 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 10504338 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 22956510 | ||
| Pubmed | The SAC domain-containing protein gene family in Arabidopsis. | 9.33e-05 | 4 | 138 | 2 | 12805586 | |
| Pubmed | Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. | 9.33e-05 | 4 | 138 | 2 | 18378882 | |
| Pubmed | Expression status of candidate genes in mesothelioma tissues and cell lines. | 9.33e-05 | 4 | 138 | 2 | 25771974 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 27777137 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 18486522 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 17342726 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 19205068 | ||
| Pubmed | 1.13e-04 | 469 | 138 | 9 | 27634302 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.26e-04 | 588 | 138 | 10 | 38580884 | |
| Pubmed | 1.36e-04 | 481 | 138 | 9 | 28190767 | ||
| Pubmed | SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation. | 1.55e-04 | 5 | 138 | 2 | 17828303 | |
| Pubmed | Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. | 1.55e-04 | 5 | 138 | 2 | 18704525 | |
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 24733019 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 19405094 | ||
| Pubmed | Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. | 1.55e-04 | 5 | 138 | 2 | 18973254 | |
| Pubmed | Methods to Study the Unique SOCS Box Domain of the Rab40 Small GTPase Subfamily. | 1.55e-04 | 5 | 138 | 2 | 34453716 | |
| Pubmed | p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates. | 1.55e-04 | 5 | 138 | 2 | 28320958 | |
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 20506312 | ||
| Pubmed | Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer. | 1.55e-04 | 5 | 138 | 2 | 33712558 | |
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 20462495 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 21965014 | ||
| Pubmed | Genetic loci influencing natural variations in femoral bone morphometry in mice. | 1.67e-04 | 27 | 138 | 3 | 11518254 | |
| Pubmed | 1.67e-04 | 27 | 138 | 3 | 20301402 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.74e-04 | 497 | 138 | 9 | 36774506 | |
| Pubmed | PDE2A CAND1 DSP PPP1R12B NCDN DDX1 EIF3CL SACM1L CUL5 DST APPL2 SACS VPS35 EXOC1 EIF3C PPP6R2 | 1.85e-04 | 1431 | 138 | 16 | 37142655 | |
| Pubmed | 1.93e-04 | 396 | 138 | 8 | 26687479 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 INCENP PPP1R12B TERF2 AKAP8L NCDN EIF3CL TUBGCP6 NBAS FANCB SYNJ2 PRKCI EIF3C CRBN | 2.11e-04 | 1155 | 138 | 14 | 20360068 |
| Pubmed | 2.32e-04 | 6 | 138 | 2 | 32513959 | ||
| Pubmed | Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G. | 2.32e-04 | 6 | 138 | 2 | 23300442 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 6.11e-09 | 13 | 101 | 5 | 685 | |
| GeneFamily | NLR family | 1.06e-05 | 25 | 101 | 4 | 666 | |
| GeneFamily | Phosphoinositide phosphatases | 2.93e-05 | 32 | 101 | 4 | 1079 | |
| GeneFamily | Parkinson disease associated genes | 8.99e-05 | 16 | 101 | 3 | 672 | |
| GeneFamily | Ubiquitin specific peptidases | 2.70e-04 | 56 | 101 | 4 | 366 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 3.56e-04 | 25 | 101 | 3 | 994 | |
| GeneFamily | Ankyrin repeat domain containing | 4.17e-04 | 242 | 101 | 7 | 403 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.46e-04 | 8 | 101 | 2 | 939 | |
| GeneFamily | Copines | 1.08e-03 | 9 | 101 | 2 | 829 | |
| GeneFamily | EF-hand domain containing | 1.44e-03 | 219 | 101 | 6 | 863 | |
| GeneFamily | ATP binding cassette subfamily A | 2.69e-03 | 14 | 101 | 2 | 805 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.47e-03 | 181 | 101 | 5 | 694 | |
| GeneFamily | Ring finger proteins | 4.45e-03 | 275 | 101 | 6 | 58 | |
| GeneFamily | Phosphodiesterases | 7.87e-03 | 24 | 101 | 2 | 681 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 USP34 SETX CAND1 USP24 TEAD1 INPP5F JARID2 BPTF NBAS THBS2 DST AKAP9 PTPRK SACS ARHGEF10 SYNJ2 PRKCI | 4.91e-07 | 856 | 136 | 18 | M4500 |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 5.77e-06 | 185 | 136 | 8 | M42503 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 7.58e-06 | 192 | 136 | 8 | M42501 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN | 1.02e-05 | 200 | 136 | 8 | M5705 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 2.26e-05 | 162 | 136 | 7 | M7005 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 3.93e-05 | 120 | 136 | 6 | M42505 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 6.46e-05 | 191 | 136 | 7 | M40019 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN | 7.60e-05 | 196 | 136 | 7 | M5008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 7.76e-05 | 84 | 136 | 5 | M13008 | |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 8.01e-05 | 44 | 136 | 4 | M2377 | |
| Coexpression | GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP | 8.36e-05 | 199 | 136 | 7 | M3071 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP | 8.63e-05 | 200 | 136 | 7 | M3514 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 8.63e-05 | 200 | 136 | 7 | M6554 | |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 8.76e-05 | 45 | 136 | 4 | MM929 | |
| Coexpression | WANG_LMO4_TARGETS_DN | 1.16e-04 | 361 | 136 | 9 | M12674 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 4.63e-06 | 105 | 134 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 9.57e-08 | 180 | 138 | 8 | daf69a548ed7c6f285a6adcff00f99aa22f9d6a5 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 164 | 138 | 7 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 164 | 138 | 7 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-06 | 172 | 138 | 7 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-06 | 180 | 138 | 7 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-06 | 181 | 138 | 7 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-06 | 181 | 138 | 7 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-06 | 181 | 138 | 7 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-06 | 181 | 138 | 7 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.76e-06 | 184 | 138 | 7 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-06 | 185 | 138 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.59e-06 | 195 | 138 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.59e-06 | 195 | 138 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-06 | 196 | 138 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.77e-06 | 197 | 138 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.96e-06 | 199 | 138 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-06 | 199 | 138 | 7 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-05 | 168 | 138 | 6 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 174 | 138 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 174 | 138 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.79e-05 | 175 | 138 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.90e-05 | 177 | 138 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.03e-05 | 179 | 138 | 6 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.30e-05 | 183 | 138 | 6 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 184 | 138 | 6 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 184 | 138 | 6 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.44e-05 | 185 | 138 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 185 | 138 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 2.59e-05 | 187 | 138 | 6 | 457eb3791a8c5458d81833e0701ac5a9bfdee2bf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 138 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.59e-05 | 187 | 138 | 6 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-05 | 188 | 138 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-05 | 188 | 138 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-05 | 188 | 138 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 2.67e-05 | 188 | 138 | 6 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.75e-05 | 189 | 138 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.75e-05 | 189 | 138 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 190 | 138 | 6 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.84e-05 | 190 | 138 | 6 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 190 | 138 | 6 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-05 | 190 | 138 | 6 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 190 | 138 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-05 | 190 | 138 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.84e-05 | 190 | 138 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.92e-05 | 191 | 138 | 6 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.92e-05 | 191 | 138 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-05 | 191 | 138 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.01e-05 | 192 | 138 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 193 | 138 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.10e-05 | 193 | 138 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.10e-05 | 193 | 138 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 3.19e-05 | 194 | 138 | 6 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-05 | 199 | 138 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.67e-05 | 199 | 138 | 6 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 3.67e-05 | 199 | 138 | 6 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | 3.67e-05 | 199 | 138 | 6 | 8194777d367405a7840787e977854b5c07e3bd6b | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.78e-05 | 200 | 138 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.92e-05 | 122 | 138 | 5 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 143 | 138 | 5 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 152 | 138 | 5 | ebce79e106bf1d84241f8dd3496ff1771f9666be | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 152 | 138 | 5 | 4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 155 | 138 | 5 | 96c48d835725eac1bc7926f4cddecb67c29b7d7c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 158 | 138 | 5 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.54e-04 | 163 | 138 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.54e-04 | 163 | 138 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 164 | 138 | 5 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.68e-04 | 166 | 138 | 5 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 166 | 138 | 5 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.73e-04 | 167 | 138 | 5 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 167 | 138 | 5 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 171 | 138 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.98e-04 | 172 | 138 | 5 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.04e-04 | 173 | 138 | 5 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.04e-04 | 173 | 138 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-04 | 175 | 138 | 5 | aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 175 | 138 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 176 | 138 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 176 | 138 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 177 | 138 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 177 | 138 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 179 | 138 | 5 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 2.38e-04 | 179 | 138 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-04 | 180 | 138 | 5 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-04 | 180 | 138 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.45e-04 | 180 | 138 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-04 | 181 | 138 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.51e-04 | 181 | 138 | 5 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.51e-04 | 181 | 138 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-04 | 181 | 138 | 5 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.57e-04 | 182 | 138 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-04 | 182 | 138 | 5 | 6e7dac78dc030f74e546b9f6db07556e9bb13ac2 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-04 | 182 | 138 | 5 | cd972d30519db706477c6b0c901165b81b74abed | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-04 | 183 | 138 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| Disease | Charcot-Marie-Tooth Disease | 1.79e-05 | 12 | 130 | 3 | C0007959 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.15e-04 | 4 | 130 | 2 | EFO_0020830 | |
| Disease | Parkinson disease | 1.21e-04 | 22 | 130 | 3 | cv:C0030567 | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 2.86e-04 | 6 | 130 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Hereditary Motor and Sensory Neuropathy Type I | 5.30e-04 | 8 | 130 | 2 | C0751036 | |
| Disease | Roussy-Levy Syndrome (disorder) | 5.30e-04 | 8 | 130 | 2 | C0205713 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ib | 5.30e-04 | 8 | 130 | 2 | C0270912 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ia (disorder) | 5.30e-04 | 8 | 130 | 2 | C0270911 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 6.47e-04 | 328 | 130 | 7 | EFO_0008377, EFO_0008378 | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0800034 | |
| Disease | Nephroblastoma | 8.47e-04 | 10 | 130 | 2 | Orphanet_654 | |
| Disease | aortic valve stenosis (is_marker_for) | 1.03e-03 | 11 | 130 | 2 | DOID:1712 (is_marker_for) | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.46e-03 | 13 | 130 | 2 | C0270914 | |
| Disease | Drug habituation | 1.70e-03 | 115 | 130 | 4 | C0013170 | |
| Disease | Drug abuse | 1.70e-03 | 115 | 130 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.70e-03 | 115 | 130 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.70e-03 | 115 | 130 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.70e-03 | 115 | 130 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.70e-03 | 115 | 130 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.70e-03 | 115 | 130 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.70e-03 | 115 | 130 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.70e-03 | 115 | 130 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.76e-03 | 116 | 130 | 4 | C0740858 | |
| Disease | quinate measurement | 1.95e-03 | 15 | 130 | 2 | EFO_0021167 | |
| Disease | retinal layer thickness measurement | 2.38e-03 | 60 | 130 | 3 | EFO_0600002 | |
| Disease | Amyotrophic lateral sclerosis | 2.51e-03 | 17 | 130 | 2 | cv:C0002736 | |
| Disease | progression free survival, ovarian carcinoma | 2.81e-03 | 18 | 130 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | cystathionine measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0010474 | |
| Disease | osteoporosis (implicated_via_orthology) | 3.14e-03 | 19 | 130 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | THSD4 USP34 PDE3A RAPH1 DDI2 FHOD3 TEC LCP1 TERF2 THBS2 FBN1 CMTR2 TRIM49B TEC | 3.37e-03 | 1392 | 130 | 14 | EFO_0005763 |
| Disease | susceptibility to chronic sinus infection measurement | 3.40e-03 | 68 | 130 | 3 | EFO_0008419 | |
| Disease | lymphocyte count, response to vaccine | 4.20e-03 | 22 | 130 | 2 | EFO_0004587, EFO_0004645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IECLMSDQECVKRNR | 2331 | Q99996 | |
| KVIECFNVESRILCM | 946 | O15013 | |
| VNMCRIQRADGDCDL | 46 | Q9NRJ3 | |
| NSVEALMECCVNALV | 256 | Q93034 | |
| RCESIITDFQVMCVA | 411 | O95196 | |
| DTINCDQFSRLLCDM | 71 | P33076 | |
| QLETISENIRLFECM | 371 | Q8IYT2 | |
| QRLRCELDIMNKCTS | 306 | Q96SW2 | |
| EQEAQMVQAAFRCCL | 651 | A5YM72 | |
| TCDMCEVARNSVLQC | 676 | P23109 | |
| DFDNFVCCLVRLETM | 671 | P07384 | |
| CRIERFLQMCDSAEE | 711 | Q96HY7 | |
| CAALVSQEQCTLMAE | 271 | Q12830 | |
| ILEEGMERFCNDLCV | 106 | Q8IWE4 | |
| EECEALCSRLAIMVN | 1986 | Q8IZY2 | |
| DRMVERIQFVCSLCK | 381 | Q9ULX6 | |
| AICRVQVMDACLRCQ | 51 | Q9UBF6 | |
| LRELCLTQFQVDMEA | 36 | O60894 | |
| MADRNKEVLLEECFC | 376 | Q70E73 | |
| KRFCQCEQRSLEQLM | 431 | Q96DU7 | |
| LCETVSSCFLNMELL | 96 | Q9Y5H2 | |
| AVQCQEDECVLMLLE | 176 | H3BUK9 | |
| CLNFDCSFIAVLMLR | 276 | Q96PH1 | |
| VAVVQDAFECSRMLC | 201 | Q16654 | |
| ATCQDQMREILSCLE | 156 | Q96LR9 | |
| RCFQMLNSLECVEIL | 166 | Q7RTW8 | |
| TLDLNRVLDEMRCQC | 251 | Q6A162 | |
| RVLDEMRCQCETVLA | 256 | Q6A162 | |
| CNEVRDMCSFDNEQL | 51 | P41743 | |
| DLRAVNINLCDMCVI | 911 | Q12791 | |
| MELGIQECTRCEQSL | 341 | Q9UBB6 | |
| CFQTREILDAMNRDC | 401 | Q14409 | |
| LLELCDQKLMEFLCN | 11 | Q9NQS7 | |
| TNLQRLMSSAEECCR | 2086 | Q8N201 | |
| QASECVVCLEREAQM | 671 | Q6UWE0 | |
| VVCLEREAQMIFLNC | 676 | Q6UWE0 | |
| RCQNVAEDMDIQLCA | 2616 | Q03001 | |
| RQCCFNMLTELVNVL | 451 | Q86VP6 | |
| MDQAIIFCRTKIDCD | 506 | Q92499 | |
| CSREMLNLLCSNALF | 246 | P07098 | |
| CMLQQAERLGCRQFV | 336 | P13796 | |
| MLFLANLECETLCQA | 556 | Q9BXM7 | |
| LEDIEIFALFISCMC | 681 | O00408 | |
| NDRLLVCQMCIKLAD | 936 | Q14432 | |
| QVSNQCMALVRDECL | 386 | Q8TAT6 | |
| ACDQNNSIMVECLLL | 716 | Q5S007 | |
| AVELSRQCQMDDCGI | 1161 | P50748 | |
| REECLCHSMIQETLQ | 166 | Q96RT7 | |
| LSEQCCEYISEMLLR | 791 | Q96MN2 | |
| ARLLCNFMRQECLDS | 81 | P25786 | |
| LMAIALECIYTCERN | 991 | A2RRP1 | |
| IALVATNLICDMRFC | 156 | Q8NGX3 | |
| SKFCCTVLLQIMERE | 591 | Q8NB91 | |
| EFELTNIDMVQCDVC | 96 | Q9NRN9 | |
| NIDMVQCDVCLLSNR | 101 | Q9NRN9 | |
| CLDCINELMDILFAN | 401 | Q99613 | |
| KCLDCINELMDILFA | 401 | B5ME19 | |
| QMIEFTEDCSCLQDR | 101 | P07320 | |
| NCEFLVNRMCRLESL | 96 | Q8NCX0 | |
| QNEEEFRCCIQELLM | 726 | Q8N1I0 | |
| CFQTREILEAMNRDC | 401 | Q14410 | |
| NEMNCCRTLRELEIQ | 151 | Q5THR3 | |
| CVDCLDRTNTAQFMV | 486 | Q92562 | |
| DRLFCVDIDECSIMN | 1191 | P35555 | |
| QTMCLDINECERDAC | 1886 | P35555 | |
| IQELLQNCSDCLMRA | 71 | P15924 | |
| QNCSDCLMRAELIVQ | 76 | P15924 | |
| EELSNCRDIATMQLC | 141 | Q8IYJ1 | |
| CRDIATMQLCANKLD | 146 | Q8IYJ1 | |
| LQDNLCQMERRCKAS | 1161 | Q2V2M9 | |
| EECEALCTRLAIMVN | 2246 | Q9BZC7 | |
| LIQDLDNCSVMAVDC | 321 | Q8NEU8 | |
| AASLLQLMDVRQNCC | 126 | Q9UH77 | |
| QLMDVRQNCCDFLQS | 131 | Q9UH77 | |
| MCVDTLFLCFLEDLE | 661 | Q53GD3 | |
| IEACTNAADALLQCM | 301 | Q9NV70 | |
| LEDQAQMAVEFKCRC | 406 | Q12794 | |
| SQACAERCNIMRLVD | 261 | Q5TDH0 | |
| CQNMELFAVLCIETS | 856 | Q9NQC7 | |
| RSNCMDCLDRTNVIQ | 386 | Q9NTJ5 | |
| EGIFRVNCMDCLDRT | 451 | Q9Y2H2 | |
| VNCMDCLDRTNVVQA | 456 | Q9Y2H2 | |
| NCRNICNITTLDEEM | 3751 | Q9NZJ4 | |
| QCMCLVDLDRARAAE | 591 | Q8NEC7 | |
| ESRRELLEQIADCCM | 1186 | Q96RY7 | |
| EELNCCRDAVLMQFC | 151 | Q86YQ8 | |
| AFCQCESLLQLMTDL | 276 | Q8NG08 | |
| LLMKSLDALENCCFD | 1116 | Q5VW36 | |
| DFLCRQQCMEELVSL | 46 | O75170 | |
| MDCDVINRIFRICNL | 1306 | Q15262 | |
| FCDINILAMFCNENR | 341 | Q96RD6 | |
| CELDLACFFRLINEM | 651 | Q92833 | |
| RNTMLLCDADCVDII | 236 | Q3ZCT8 | |
| MSELRLCCDLLVQQV | 1 | O95397 | |
| SIQMVDCCKRLLEQS | 446 | Q8N3R3 | |
| TLCVVCMCDFESRQL | 461 | Q9H0F5 | |
| MDCINIRTGQECRDT | 51 | Q96CS7 | |
| METLSQDSLLECQIC | 1 | Q8N8N0 | |
| TLRMNCLDCLDRTNT | 381 | O15056 | |
| FSRDVLLSMCQDVCE | 461 | P42680 | |
| VCQCDDNMVQRLETD | 541 | P48380 | |
| AVQCQEDECVLMLLE | 176 | A0A0A6YYL3 | |
| NLNMIETFICQVCEE | 671 | Q96D09 | |
| AVQCQEDECALMLLE | 176 | P0CG39 | |
| CCIDDFREMVQQLLE | 111 | Q96I34 | |
| RMLESLSCECEAIKQ | 71 | Q96EA4 | |
| ELCVEALCRMEQANC | 131 | Q7Z333 | |
| QMLSLENCRLTEASC | 821 | Q8WX94 | |
| EREIIHVLMDCCLQE | 686 | Q5C9Z4 | |
| VCDDTMVCRLDSAVQ | 291 | Q9P291 | |
| DVICETRRNSICEMN | 191 | Q6EIG7 | |
| IMCSANCAILLFINE | 76 | Q9NYW7 | |
| LARLCSQMEARQKEC | 31 | Q3KNT9 | |
| MQTLQEEAVCAICLD | 11 | Q96A61 | |
| VESALCALRNCIAFM | 431 | Q9H4B4 | |
| MNNLLCCALVFLDIS | 1 | O00300 | |
| DVMLETCRNLASLDC | 31 | Q15935 | |
| VRECQLQVFLRLEMC | 716 | Q7Z2Z1 | |
| ECCMAILLSQIVFIE | 56 | Q86VN1 | |
| SSLRDRMVAFCELCQ | 771 | Q9UJ98 | |
| RMVAFCELCQSCLSD | 776 | Q9UJ98 | |
| RCVDILELCEQEDLM | 1541 | Q15413 | |
| VNCRDALAQEYLMEC | 251 | Q96QK1 | |
| CREAASLVEDLTQMC | 106 | Q8NBB4 | |
| NFCENLALIMCERTH | 51 | Q6U7Q0 | |
| RQLAQEQFFLMCTRC | 1331 | O00507 | |
| IMNEEQTALFCSACR | 151 | O60290 | |
| LMENLREELTCFICL | 6 | Q8N9V2 | |
| RSEEMCLSQLFLQVE | 6 | Q9HBG4 | |
| ARMLEIQCIVNVCLE | 111 | A1YPR0 | |
| SQCMEYFDLRCQLLD | 1506 | Q9UPU5 | |
| LDILENFEENCCVMR | 86 | Q96DR4 | |
| ANSDIFLCEILRSMC | 296 | A6NDI0 | |
| MCENCADLVEVLNEI | 1 | Q70CQ2 | |
| CERSCEELGNMVQEL | 266 | P35442 | |
| VTNRDTQETLLCMAC | 391 | P28347 | |
| EVRCLSDDMTLSNLC | 936 | Q6ZMP0 | |
| ACNEQQRTTMILLCE | 2221 | Q5T4S7 | |
| SDVDMFCREVSILCQ | 501 | Q59H18 | |
| TKAVQCREDECALML | 211 | Q6S5H5 | |
| VQCQEDECALMLLEH | 251 | Q6S545 | |
| TARMFLLRGQCCLEE | 511 | A8MYJ7 | |
| MQCLSRIEEGENLDC | 146 | Q15554 | |
| CLLDCVVVDLQDMDI | 2151 | Q5THJ4 | |
| LQDLELMGCVLTNAC | 931 | Q86W24 | |
| AMIQCSLEACRILDT | 426 | Q9BWU0 | |
| CSILAEALCDMDIRN | 266 | O60237 |